Title:
ALBUMIN FUSION PROTEINS
Document Type and Number:
WIPO Patent Application WO2001079443
Kind Code:
A3
Abstract:
The present invention encompasses albumin fusion proteins. Nucleic acid molecules encoding the albumin fusion proteins of the invention are also encompassed by the invention, as are vectors containing these nucleic acids, host cells transformed with these nucleic acid vectors, and methods of making the albumin fusion proteins of the invention and using these nucleic acids, vectors, and/or host cells. Additionally the present invention encompasses pharmaceutical compositions comprising albumin fusion proteins and methods of treating, preventing, or ameliorating diseases, disorders or conditions using albumin fusion proteins of the invention.
Inventors:
ROSEN CRAIG A (US)
HASELTINE WILLIAM A (US)
HASELTINE WILLIAM A (US)
Application Number:
PCT/US2001/011924
Publication Date:
February 21, 2002
Filing Date:
April 12, 2001
Export Citation:
Assignee:
HUMAN GENOME SCIENCES INC (US)
ROSEN CRAIG A (US)
HASELTINE WILLIAM A (US)
ROSEN CRAIG A (US)
HASELTINE WILLIAM A (US)
International Classes:
C12N15/09; A61K35/12; A61K35/76; A61K38/00; A61K38/21; A61K38/22; A61K38/23; A61K38/27; A61K38/28; A61K38/43; A61K38/46; A61K38/48; A61K38/55; A61K39/395; A61K47/48; A61K48/00; A61P1/00; A61P1/04; A61P1/16; A61P1/18; A61P3/10; A61P3/14; A61P5/00; A61P5/10; A61P5/14; A61P5/40; A61P7/00; A61P7/04; A61P7/06; A61P9/00; A61P9/06; A61P9/10; A61P9/12; A61P11/00; A61P11/06; A61P13/00; A61P13/02; A61P13/08; A61P13/12; A61P15/00; A61P15/08; A61P15/10; A61P15/18; A61P17/00; A61P17/02; A61P17/06; A61P17/12; A61P17/14; A61P19/00; A61P19/02; A61P19/08; A61P19/10; A61P21/00; A61P21/04; A61P25/00; A61P25/02; A61P25/08; A61P25/16; A61P25/28; A61P27/02; A61P29/00; A61P31/00; A61P31/12; A61P31/14; A61P31/16; A61P31/18; A61P31/20; A61P31/22; A61P33/02; A61P33/06; A61P33/12; A61P35/00; A61P35/02; A61P35/04; A61P37/00; A61P37/02; A61P37/04; A61P37/06; A61P37/08; A61P39/02; A61P41/00; A61P43/00; C07K14/47; C07K14/55; C07K14/56; C07K14/565; C07K14/585; C07K14/60; C07K14/61; C07K14/62; C07K14/635; C07K14/65; C07K14/705; C07K14/715; C07K14/745; C07K14/75; C07K14/76; C07K14/765; C07K14/81; C07K16/00; C07K19/00; C12N1/15; C12N1/19; C12N1/21; C12N5/02; C12N5/10; C12N9/14; C12N9/74; C12N9/99; C12N15/62; A61K39/00; (IPC1-7): C07K1/00; A01N37/18
Domestic Patent References:
| WO1993015199A1 | 1993-08-05 | |||
| WO1993015211A1 | 1993-08-05 | |||
| WO1996018412A1 | 1996-06-20 |
Other References:
YEH ET AL.: "Design of yeast-secreted albumin derivatives for human therapy: Biological and antiviral properties of a serum albumin-CD4 genetic conjugate", PROC. NATL. ACAD. SCI. USA, vol. 89, March 1992 (1992-03-01), pages 1904 - 1908, XP002948204
Download PDF: